Is there any place for a wait-and-see policy in stage I0 follicular lymphoma?

Jaffe, 1983, Follicular lymphomas: Possibility that they are benign tumors of the lymphoid system, J Natl Cancer Inst, 70, 401

Hœrni, 1985, Follicular lymphomas, J Eur Radiother, 6, 121

Macmanus, 1996, Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University, J Clin Oncol, 14, 1282, 10.1200/JCO.1996.14.4.1282

McLaughlin, 1986, Stage I-II follicular lymphoma. Treatment results for 76 patients, Cancer, 58, 1596, 10.1002/1097-0142(19861015)58:8<1596::AID-CNCR2820580803>3.0.CO;2-G

Paryani, 1983, Analysis of non- Hodgkin's lymphomas with nodular and favorable histologies, stages I and II, Cancer, 52, 2300, 10.1002/1097-0142(19831215)52:12<2300::AID-CNCR2820521224>3.0.CO;2-Y

Soubeyran, 1988, Localized follicular lymphomas: Prognosis and survival of stages I and II in a retrospective series of 103 patients, Radiother Oncol, 13, 91, 10.1016/0167-8140(88)90030-8

Horning, 1993, Natural history of and therapy for the indolent non-Hodgkin's lymphomas, Semin Oncol, 20, 75

Horning, 1984, The natural history of initially untreated low-grade non-Hodgkin's lymphomas, N Engl J Med, 311, 1471, 10.1056/NEJM198412063112303

Portlock, 1979, No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types, Ann Intern Med, 90, 10, 10.7326/0003-4819-90-1-10

Lennert, 1992

The non-Hodgkin's lymphoma pathologic classification project, 1982, National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas, Cancer, 49, 2112, 10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2

Denham, 1996, The follicular non- Hodgkin's lymphomas. 2. Prognostic factors: What do they mean?, Eur J Cancer, 32 A, 480, 10.1016/0959-8049(95)00635-4

Chauvergne, 1977, Induction chemotherapy of non-Hodgkin's lymphomas. Preliminary results of a controlled trial, Eur J Cancer, 13, 399, 10.1016/0014-2964(77)90089-5

Dixon, 1987, Reporting outcomes in Hodgkin's disease and lymphoma, J Clin Oncol, 5, 1670, 10.1200/JCO.1987.5.10.1670

Soubeyran, 1987, Treatment of follicular lymphomas at limited stage III. Advantages of radiotherapy, J Eur Radiother, 8, 61

Coiffier, 1993, Prognostic factors in follicular lymphomas, Semin Oncol, 20, 89

Soubeyran, 1989, Relapses of follicular lymphomas. Prognosis and survival in a retrospective series of 92 patients and 129 relapses, J Eur Radiother, 10, 65

Lister, 1991, The management of follicular lymphoma, Ann Oncol, 2, 131, 10.1093/annonc/2.suppl_2.131

Landberg, 1979, CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas. Preliminary results of a randomized study, Cancer, 44, 831, 10.1002/1097-0142(197909)44:3<831::AID-CNCR2820440307>3.0.CO;2-S

Monfardini, 1981, Improved five-year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma, Int J Radiat Oncol Biol Phys, 6, 125, 10.1016/0360-3016(80)90027-9

Nissen, 1983, A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphoma, Cancer, 52, 1, 10.1002/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M

Solal Celigny, 1993, Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Étude des Lymphomes de l'Adulte, N Engl J Med, 329, 1608, 10.1056/NEJM199311253292203

Brice, 1995, A randomized study in low tumor burden follicular lymphoma between no treatment, prednimustine and interferon, J Clin Oncol, 14, 394

Meerwaldt, 1991, Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern, Int J Radiat Oncol Biol Phys, 21, 1167, 10.1016/0360-3016(91)90272-6

Richaud, 1979, Total body irradiation (TBI). Preliminary results of a new technique used in 30 patients with hematologic malignancies, Strahlenther Onkol, 155, 736

Gribben, 1994, Attainment of molecular remission: A worthwhile goal?, J Clin Oncol, 12, 1532, 10.1200/JCO.1994.12.8.1532

Sklar, 1991, Polymerase chain reaction; The molecular microscope of residual disease, J Clin Oncol, 9, 1521, 10.1200/JCO.1991.9.9.1521

Gribben, 1991, AU advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment, Blood, 78, 3275, 10.1182/blood.V78.12.3275.3275

Lee, 1987, Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification, Science, 237, 175, 10.1126/science.3110950

Meijerink, 1993, Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction, Br J Haematol, 84, 250, 10.1111/j.1365-2141.1993.tb03060.x

Soubeyran, 1993, Analysis of the expression of the hybrid gene bcl-2/lgH in follicular lymphomas, Blood, 81, 122, 10.1182/blood.V81.1.122.122

Gribben, 1993, Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma, Blood, 81, 3449, 10.1182/blood.V81.12.3449.3449

Johnson, 1994, Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma, J Clin Oncol, 12, 798, 10.1200/JCO.1994.12.4.798

Negrin, 1994, Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase, J Clin Oncol, 12, 1021, 10.1200/JCO.1994.12.5.1021

Price, 1991, The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma, J Clin Oncol, 9, 1527, 10.1200/JCO.1991.9.9.1527

Campana, 1995, Detection of minimal residual disease in acute leukemia; Methodological advances and clinical significance, Blood, 85, 1416, 10.1182/blood.V85.6.1416.bloodjournal8561416

Soubeyran, 1991, Low-grade follicular lymphomas; Analysis of prognosis in a series of 281 patients, EurJ Cancer, 27, 1606, 10.1016/0277-5379(91)90425-D